The agency’s accelerated approval of the medication was welcomed by some advocates and doctors as a step forward in treating the devastating disease but strongly criticized by many experts who say the medication hasn’t been shown to be effective.
House committees step up investigation into FDA approval of controversial Alzheimer’s drug
